Repligen Reports Q1 2026 Earnings and Strategic Updates
Repligen (RGEN) reported strong financial performance for the first quarter of 2026, with a 15% increase in revenue driven by organic growth. The company also highlighted strategic advancements including the launch of its transformation office, sale of the polymer business, and a new partnership in China.
Tickers: $RGEN
Topics: operating_margin_expansion revenue_growth strategic_initiatives